Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · Real-Time Price · USD
36.84
-0.88 (-2.33%)
Aug 7, 2025, 3:26 PM - Market open
Agios Pharmaceuticals Market Cap
Agios Pharmaceuticals has a market cap or net worth of $2.14 billion as of August 7, 2025. Its market cap has decreased by -21.04% in one year.
Market Cap
2.14B
Enterprise Value
859.11M
1-Year Change
-21.04%
Ranking
Category
Stock Price
$36.84
Market Cap Chart
Since July 24, 2013, Agios Pharmaceuticals's market cap has increased from $919.00M to $2.14B, an increase of 132.91%. That is a compound annual growth rate of 7.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2025 | 2.19B | 16.95% |
| Dec 31, 2024 | 1.87B | 50.56% |
| Dec 29, 2023 | 1.24B | -19.33% |
| Dec 30, 2022 | 1.54B | -13.57% |
| Dec 31, 2021 | 1.79B | -40.52% |
| Dec 31, 2020 | 3.00B | 6.73% |
| Dec 31, 2019 | 2.81B | 4.81% |
| Dec 31, 2018 | 2.68B | -3.76% |
| Dec 29, 2017 | 2.79B | 58.97% |
| Dec 30, 2016 | 1.75B | -28.25% |
| Dec 31, 2015 | 2.44B | -37.12% |
| Dec 31, 2014 | 3.89B | 420.55% |
| Dec 31, 2013 | 746.50M | -18.77% |
| Jul 24, 2013 | 919.00M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 670.04B |
| Johnson & Johnson | 410.84B |
| AbbVie | 346.78B |
| AstraZeneca | 228.71B |
| Abbott Laboratories | 227.88B |
| UnitedHealth Group | 222.96B |
| Novartis AG | 221.76B |
| Novo Nordisk | 200.63B |